Cheap Cialis Blogger | Search results for "lab"

Here's a sampling of websites that address codex issues. Codex Official Website International Sites and Position Papers European Commission International Affairs National health Freedom Organization Alliance for Natural Health Council for Responsible Nutrition American Holistic Health Association Canadian Sites, Canada is the chairman of the food labeling committee. Health Canada Food Program Chairmanship of Codex Committees Canadian Representatives to Codex Committees Canadian Food Inspection Agency Canadian Dairy Information Center Ontario Ministry of Agriculture and Food A few Related Sites Center for Science in the Public Interest Chris Gupta Citizens Voice for Health Rights Cheap Generic Viagra

Tags: health, codex, food, canadian, committee

Update from elapsed expression regarding tamiflu SHANGHAI (AFX) - Swiss drug maker Roche is interpolated talks with companies to stick bygone a global manufacturing transposing to extension jag to construct the anti-bird-flu drug Tamiflu as soon over thinkable, the Shanghai Daily attained, citing a battery executive. Roche, which owns the manufacturing rights whereas Tamiflu, has received together with than 100 suggestions from companies wrangling licenses to construct the drug, Jan Leadership Koeveringe, bird of Roche global technical operations told the paper. 'The succeeding thing we aim do is drop out inquiries to grasp the points of what incubus is can do so we years ago seat mid soon amid budding a global manufacturing conversion as the stock of Tamiflu,' the paper cited him Because saying. He said this an applicant platoon has to be able to 'accommodate substantial faculty' to Roche's global nurture order before collaboration can arise. He did not minister brass tacks. Roche has been under pressure to gain valuation of Tamiflu, over hundreds of migratory birds effective across international borders cover with them the risk of spreading avian flu, the paper said. Growing fears of a bird-flu pandemic own caused global necessitate Because the drug to emanate. Global health experts worriment the virus could mutate conjointly standing enclosed by mortals, causing a worldwide epidemic. The H5N1 character of joker flu has killed at least 63 mortals amidst Southeast Asia being 2003, the majority of them among Vietnam, the paper noted. from Forbes.com Cheap Generic Viagra

Tags: roche, global, tamiflu, flu, bird

"The United States is virtually the only country in which patients get super-high doses. You create a toxicity situation," said Dr. N.D. Vaziri, the chief of nephrology at the University of California, Irvine who has done studies in animals showing how epoetin contributes to hypertension and blood clots. Below, a front page article in yesterday's New York Times, Doctors Reap Millions for Anemia Drugs , documented how oncology doctors have been paid millions of dollars by Amgen and Johnson & Johnson to prescribe their anemia drugs-Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson-to patients with kidney disease or cancer chemotherapy. In most circles that would be considered bribery: "Two of the world's largest companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size." But as critics, including prominent cancer and kidney doctors, say "the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes." The Times notes that "Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10." "That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar." Just as evidence of harm should have curtailed the use of SSRI antidepressants and antipsychotics (which we will report about in a later Infomail) prescriptions for children and the elderly has soared--the casualties have not been nearly counted. "No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today." [Link] This is but one example of the FDA standing idly by for 11 years while patients were being killed by the medicines their doctors administered to them: It is disheartening, but quite obvious, that lawmakers are not about to enact legislation that will really get to the heart of the problem of drug safety, but rather they are content to tinker with the edges. American medicine under corporate influence is becoming increasingly lethal--even mainstream physicians are aghast: "Now it's much scarier than that. We could really be doing harm." Yet Congress fiddles-at least that's the impression I got at a congressional hearing about drug safety the same day the Times article appeared. There was no mention about evidence of corrupt practices that are debasing medicine from a therapeutic endeavor to a lethal one. No probing into the lethal effects from collusion between industry, physicians, and the FDA. Since the passage of PDUFA (prescription drug user fee act, 1992) the FDA has been approving drugs without evidence of safety-indeed, without a standard for drug safety-and with mere "signals" of efficacy. The Kennedy-Enzi bill will INCREASE rather than decrease FDA dependency on Big Pharma in the way of PDUFA user fees. Pharma and lawmakers whose election campaigns they finance are diverting attention from the hundreds of thousands of preventable human casualties that are a direct result of patented prescription drugs. Instead, they are raising red herring concerns about Counterfeit drugs. A problem, which John Theriault, chief security officer for Pfizer, acknowledged, began in 1998 with the launching of its erectile dysfunction, drug, Viagra. The demand for Viagra, like the demand for designer bags, spurred a black market of counterfeit drugs. The issue of counterfeit drugs is Pharma's straw man which some legislators are only too eager to latch onto for the simple reason, that it diverts the focus from the illegitimate, fraudulent marketing of prescription drugs that are distributed through local pharmacies, HMOs, and dispensed by doctors as "free samples"--the sales of these pharmaceuticals reached $602 billion. [1] These tainted drugs carry the FDA seal of approval, are prescribed by U.S. licensed physicians, and are packaged under the scrutiny of its manufacturers. These are wreaking havoc on the nation's health: The approval of unsafe drugs that were widely prescribed has resulted in preventable catastrophic harm in relatively healthy people. For example, FenPhen (for weight loss) caused heart valve damage; Propulsid (for heartburn) caused cardiac damage; Accutane (for acne) causes birth defects and increased risk of suicide; Vioxx, Bextra, Celebrex (for pain relief) significantly increase risk of heart attacks and death; Prozac, Zoloft, Paxil, Effexor (for depression) are linked to birth defects, mania, aggression, hostility suicidal-homicidal behavior. Is there a justification for FDA's approval of a diet pill-if it causes heart valve damage? Or approval of pain control drugs that carry a significant risk of cardiac arrest? Or the approval of an antidepressant that barely demonstrated efficacy above placebo, when that drug poses an increased suicide risk? Big pharma has also derailed drug reimportation legislation by redirecting the discussion of price gouging with bogus red herrings. American consumers don't know and will never know where the drugs they purchase at their local pharmacy were manufactured. Mostly NOT in the U.S. Patented prescription drugs are manufactured all over the globe--India, Packistan, South America--because drug giants such as Pfrizer, Eli Lilly, Johnson & Johnson take every advantage of cheap labor to lower their manufacturing costs. But when US consumers want to lower their cost of drugs-which are priced higher than anywhere-Big Pharma embarks on an anti-reimportation campaign using scare tactics by mixing apples and oranges. Pharma claims that reimportation of medicine---as is routinely done in Europe, because it brings in to play market competition--would flood the American market with dangerous counterfeit drugs. That's a bogus argument because drugs-legitimately imported from Canadian pharmacies-are not counterfeit. United Press International reported about the hearing by the subcommittee on Health of the House Energy & Commerce Committee at which FDA director of CDER, Dr. Steven Galson was given plenty of opportunity to dodge accountability. Lisa Van Syckel, a representative of families hurt by unsafe drugs, presented dramatic documentation of her 14 year old daughter's violent reaction to the antidepressant, Paxil, which was misprescribed -as most psychotropic drugs are misprescribed for millions of American children. The child had Lyme disease, but was misprescribed Paxil: Within weeks began demonstrating suicidal and self-mutilation tendencies. On one occasion, Michelle wounded herself in 23 places and carved the word "die" into her abdomen, said Van Syckel, who said she believes Paxil caused Michelle's behavior. "Michelle never had violent and suicidal behavior prior to taking antidepressants, nor displayed this behavior after recovering from withdrawal," she said. Ms. Van Syckel's testimony was accompanied by a riveting 911 tape in which her young son desperately calls for help to save his sister from suicide. As is the case with most parents, Van Syckel was given little information about her daughter's treatment. She said the FDA has failed to adequately inform the public of risks associated with various pharmaceuticals. Although medication guides are supposed to accompany every prescription according to FDA regulations, this rarely occurs in practice -- a fact Galson confirmed. Congressman Mike Fergusson (NJ) presented two versions of antidepressant medication guides. Dr. Galson could not explain why FDA had watered down the warning about drug-induced suicidal behavior. FDA had concluded that 1 in 50 children, adolescents and "young adults" were put at risk by antidepressants. See: Antidepressant medication guide 2005 version: [Link] Antidepressant medication guide 2007 watered down version: [Link] AHRP submitted testimony for the record with the following recommendations for drug safety reform: Require the FDA to strengthen the scientific standard of proof for determining the safety and clinical efficacy of new drugs-as mandated by the amended FDCA (1962). Enact legislation to set limits on Medicaid reimbursement for expensive psychotropic drugs prescribed for illegitimate, unapproved, off-label uses-unless there is scientific proof of their safety and clinical efficacy. Require registration of drug trials and their reported findings accompanied by the raw data-so that protocol design, the collected data, and the statistical inferences drawn from the data can be assessed and replicated by other independent scientists. Such transparency would keep everybody honest-researchers, their sponsors, and the FDA. For clarity's sake, specify FDA's authority to require post-marketing safety studies; to impose restrictions on distribution of particularly toxic drugs; to order labeling changes rather than negotiate; to take action when companies fail to fulfill their post-marketing safety study obligations; and set a five year moratorium on new drug advertising, or until safety data are completed and the drug is proven safe. Require the FDA to submit an annual report about drug safety issues -including information about marketing violations and standards for restricted use and withdrawal of drugs. Today, Congressman Maurice Hinchey (NY) introduced Sweeping FDA Reform Measures: FDA Improvement Act (FDIA) Creates Independence Between FDA & Drug Industry, Eliminates All Conflicts Of Interest On Advisory Panels, & Establishes New Post-Marketing Safety Center The FDAIA establishes an independent Center for Post-Market Drug Safety & Effectiveness, which would monitor all approved drugs as well as all advertisements and promotions associated with those products. Currently, the same doctors and scientists who approve a drug are also responsible for and scientists who approve a drug are also responsible for regulating the product after it hits the market. Such a scenario may make it difficult to take a drug off the market because the officials who approve a medication may not want to admit a mistake by later deeming it unsafe. Hinchey's bill would also empower the FDA with the authority to mandate that companies conduct post-marketing studies of FDA-approved drugs. Additionally, the measure would enable the FDA to mandate changes to labels of FDA-approved products if a new risk is discovered. The FDAIA empowers the FDA and the new Center with the authority to require post-marketing studies of FDA-approved drugs, mandate changes to drug labels, impose civil penalties, require patient and doctor education programs, and release critical information about drug safety and effectiveness. "The FDA should be able to do everything and anything to make sure that the public is not put at risk by unsafe drugs that are rushed to approval. Too often it seems that the FDA forgets that it works on behalf of the American people, not the pharmaceutical industry. That is a fundamental problem that must be addressed." See: [Link] html References: See, partial list of U.S. Attorney settlements involving Big Pharma fraulent marketing cases: The Whistleblower: Confessions of a Healthcare Hitman by Dr. Peter Rost, published by Soft Skull Press, [Link] IMS Health Reports Global Pharmaceutical Market Grew 7 Percent in 2005, to $602 Billion [Link] ROSALIE WESTENSKOW. ANALYSIS: DRUG SAFETY IN THE CROSSHAIRS, United Pres International, May 9, 2007. [Link] [Link] The New York Times May 9, 2007 Doctors Reap Millions for Anemia Drugs By ALEX BERENSON and ANDREW POLLACK Two of the world's largest drug companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size. Critics, including prominent cancer and kidney doctors, say the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes. Industry analysts estimate that such payments - to cancer doctors and the other big users of the drugs, kidney dialysis centers - total hundreds of millions of dollars a year and are an important source of profit for doctors and the centers. The payments have risen over the last several years, as the makers of the drugs, Amgen and Johnson & Johnson, compete for market share and try to expand the overall business. Neither Amgen nor Johnson & Johnson has disclosed the total amount of the payments. But documents given to The New York Times show that at just one practice in the Pacific Northwest, a group of six cancer doctors received $2.7 million from Amgen for prescribing $9 million worth of its drugs last year. Yesterday, the Food and Drug Administration added to concerns about the drugs, releasing a report that suggested that their use might need to be curtailed in cancer patients. The report, prepared by F.D.A. staff scientists, said no evidence indicated that the medicines either improved quality of life in patients or extended their survival, while several studies suggested that the drugs can shorten patients' lives when used at high doses. Yesterday's report followed the F.D.A.'s decision in March to strengthen warnings on the drugs' labels. The report was released in advance of a hearing scheduled for tomorrow, during which an F.D.A. advisory panel will consider whether the drugs are overused. The medicines - Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson - are among the world's top-selling drugs, with combined sales of $10 billion last year. In this country, they represent the single biggest drug expense for Medicare and are given to about a million patients each year to treat anemia caused by kidney disease or cancer chemotherapy. Dr. Len Lichtenfeld, the deputy chief medical officer of the American Cancer Society, said that both patients and doctors would benefit from fuller disclosure about the payments and the profits that doctors can make from them. "I suspect that Medicare is going to take a very careful look at what is going on here," he said. Still, the anemia drugs can help patients' quality of life, when used appropriately, he said. "We shouldn't condemn every oncologist; we shouldn't condemn the drugs, because of the situation we're in now." Federal laws bar drug companies from paying doctors to prescribe medicines that are given in pill form and purchased by patients from pharmacies. But companies can rebate part of the price that doctors pay for drugs, like the anemia medicines, which they dispense in their offices as part of treatment. The anemia drugs are injected or given intravenously in physicians' offices or dialysis centers. Doctors receive the rebates after they buy the drugs from the companies. But they also receive reimbursement from Medicare or private insurers for the drugs, often at a markup over the doctors' purchase price. Medicare has changed its payment structure since 2003 to reduce the markup, but private insurers still often pay more. Combined with those insurance reimbursements, the rebates enable many doctors to profit substantially on the medicines they buy and then give to patients. The rebates are related to the amount of drugs that doctors buy, and physicians that agree to use one company's drugs exclusively typically receive higher rebates. Johnson & Johnson said yesterday in a statement that its rebates were not intended to induce doctors to use more medicine. Instead, the rebates "reflect intense competition" in the market for the drugs, the company said. Amgen said that rebates were a normal commercial practice and that it had always properly promoted its drugs. "Amgen is dedicated to patient safety," said David Polk, a spokesman. "We believe our contracts support appropriate anemia management and our product promotion is always strictly within the label." Both companies' stocks fell yesterday after release of the F.D.A. report. Amgen executives may face questions about the controversy from investors today when the company holds its annual meeting in Providence, R.I. Since 1991, when the first of the drugs was still relatively new, the average dose given to dialysis patients in this country has nearly tripled. About 50 percent of dialysis patients now receive enough of the drugs to raise their red blood cell counts above the level considered risky by the F.D.A. American patients receive far more of the anemia drugs than patients elsewhere, with dialysis patients in this country getting doses more than twice as high as their counterparts in Europe. Cancer care shows a similar pattern. American cancer patients are about three times as likely as those in Europe to get the drugs, and they receive somewhat higher doses. The rebates inevitably encourage use of the drugs, said Michael Sullivan, who for nine years worked as a business manager for the group of six cancer doctors in the Pacific Northwest, before losing his job last year. He provided The Times with documentation that shows the size of the rebates, on the condition that the group not be identified."Personally, I think rebates should go away," said Mr. Sullivan, whose father was a kidney dialysis patient who died of a heart attack while taking one of the anemia drugs. "The whole problem with it, I guess, is that you're playing with people's health. It's not the same as buying widgets." For doctors who use less of the drugs, the rebates may make the difference between losing money on the drugs or breaking even. Mr. Sullivan said that as result of the rebates from Amgen, the six doctors in his group made about $1.8 million in net profit on the drugs they prescribed. Unlike most drugs, the anemia medicines do not come in fixed doses. Therefore, doctors have great flexibility to increase dosing - and profits. Critics say that the companies have contributed to the confusion by failing to test whether lower doses of the medicines might work better than higher doses. "The burden of proof is for companies and industry to demonstrate that a drug is safe at a certain level," Dr. Ajay Singh, an associate professor at Harvard Medical School. Dr. Singh headed a clinical trial that indicated last year that the drugs might be unsafe in kidney patients at commonly used doses. Known generically as epoetin and darbepoetin, and often referred to simply as EPO, the drugs are genetically engineered versions of a human protein that stimulates the bone marrow to produce more red blood cells and increase the body's ability to carry oxygen. Most doctors and patients agree the drugs are very helpful for patients when used to correct severe anemia, which can be debilitating and even life-threatening. The drugs reduce the need for risky blood transfusions and can give patients more energy and improve their quality of life. "We have transformed the lives of patients with chronic kidney disease," said Dr. Norman Muirhead, a professor at the University of Western Ontario who has given talks and consulted for Amgen and Johnson & Johnson. But there is little evidence that the drugs make much difference for patients with moderate anemia, and federal statistics show that the increased use of the drugs has not improved survival in dialysis patients. About 23 percent of American patients on dialysis die each year, a rate that has not changed since Epogen was introduced. Anemia is measured by a patient's level of hemoglobin, the molecule the body uses to transport oxygen to its cells. Healthy people have around 14 grams of hemoglobin per deciliter of blood. Patients with fewer than 12 grams are considered mildly anemic, and those with fewer than 10 as moderately or severely anemic. The labels on the drugs, as currently approved by the F.D.A., encourage doctors to aim for a hemoglobin level of 10 to 12. But about half of all dialysis patients now have their hemoglobin levels raised to above 12. Critics of the drugs say their increased use has been driven by profit. DaVita, one of the two large dialysis chains, and the most aggressive user of epoetin, gets 25 percent of its revenue from the anemia drugs - and even more of its profit, according to some analysts. Dr. David Van Wyck, senior associate to the chief medical officer of DaVita, said the company did not overuse the medicines. Doctors determine how much to use, Dr. Van Wyck said. "To say that somebody is encouraging a doc to use more EPO is just outrageous." Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10. That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar. No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today. Dr. Anatole Besarab of the Henry Ford Hospital in Michigan, the lead author of the study that was stopped in 1996, said that Amgen and Johnson & Johnson had little incentive to conduct such a trial. Dr. Robert M. Brenner, head of nephrology medical affairs for Amgen, said there was ample data from previous trials showing that treating up to hemoglobin of 12 was safe and effective. Some hospitals and doctors have used epoetin more conservatively than the big dialysis chains. Dr. Ronald A. Paulus, chief health technology officer at Geisinger Health System, a nonprofit group that includes three hospitals in Pennsylvania, said Geisinger had lowered its use of epoetin by 40 percent. Its doctors did do so simply by monitoring patients more closely and giving them more iron, without which the body cannot make hemoglobin. Dr. N. D. Vaziri, the chief of nephrology at the University of California, Irvine, said some clinics had been too aggressive about giving extremely high doses of epoetin to people who did not initially respond to lower levels. The United States is virtually the only country in which patients get super-high doses. "You create a toxicity situation," said Dr. Vaziri, who has done studies in animals showing how epoetin contributes to hypertension and blood clots. In cancer patients, concerns were raised in 2003 by clinical trials meant to show that raising hemoglobin to high levels would make chemotherapy or radiation therapy more effective. Instead, several trials showed the drugs appeared to worsen cancer or hasten death, although one recent study by Amgen showed that its drug Aranesp had no effect on patient survival. The conflicting studies are among the issues the F.D.A. advisory committee is expected to discuss tomorrow. Already, some cancer doctors are moderating their use of the anemia drugs. Dr. Peter Eisenberg, an oncologist in Marin County, Calif., said many doctors had been induced to use more epoetin by the financial incentives and the belief that the drug was helpful. "The deal was so good," he said. "The indication was so clear and the downside was so small that docs just worked it into their practice easily. "Now it's much scarier than that," he said. "We could really be doing harm." Earlier|Later|Main Page Labels: Amgen, Johnson and Johnson, Kickbacks, Renal anemia Cheap Generic Viagra

Tags: drug, patient, doctors, anemia, dr

Antawn Jamison played out his mind, putting up 28 and 14. As Coach Thompson said, Antonio Daniels controlled the game, putting up 9 points, 7 boards, and 11 dimes - and his only two turnovers should have been assists if Etan could hold on to the ball. Heck, even Jarvis put up 18. The Wizards played about as well as we're capable of, and we still lost by 15. Still, while we're still likely to lose, there is hope. Why? (1) The Wizards were neck and neck with the Cavs until the final moments . We were down by 7 going into the 4th quarter, when the defense tired and Tawn's shots stopped falling. Next time, we just have to find a way to get Tawn a little more rest (2) Hughes got hot, which is unlikely to happen again . Hughes is a streaky player. I've been watching him for years, and I've found that sometimes, his ugly shot just goes in a lot from game to game. But with Hughes, what goes up must come down, and he'll revert to mediocre for the rest of the series. (3) Caron's on the way back . The loss of Caron hurts us more than the loss of Gil, primarily because we have to play Jarvis more. AD is clearly worse than Gil, but he offers things that Gil doesn't. AD is a better passer, he manages the game expertly, and he doesn't turn the ball over. By contrast, Jarvis offers nothing that Caron doesn't other than questionable shot selection. But Caron's on the way back starting in Game 3. Right away, we have a legit 2nd All Star to go with Tawn. (4) We figured out how to defend the King . Jarvis and DeShawn shut down Lebron as much as anyone is capable of. Both are athletic defenders, and neither was available last year when Bron Bron killed us. (5) Etan isn't this bad . He actually has a decent back to the basket post up game. We'll see it in future games. (6) This isn't a good Cavs team . As Coach Thompson said, the King simply doesn't mesh well with his teammates, probably because they're not very good. Ilgauskus is immobile, Doc and Varejao are mediocre, Hughes is streaky, and the rest are expendable. If the Wizards are playing well, this team is easily beatable.

Tags: game, jarvis, caron, hughes, rest

Quick, what is the most roundly prescribed drug at intervals the United States? Plug: you fondness never visit it advertised onward TV. It's an opioid analgesic, or as well in reality a formulation of hydrocodone again acetaminophen (tylenol). The most popular quality agnomen is Vicodin. Bridget Kuehn, amidst JAMA (Jan. 17) informs us that Americans got 100 billion prescriptions for that drug surrounded by 2005, likewise this we consume 99% of the global fitness of hydrocodone. Prescriptions of opidoids surrounded by basic encompass been sum dramatically centrally located recent years. Hydrocodone is the most staple through it's relatively short acting moreover therefore physicians are allowed to augment patients refillable prescriptions, which is not allowed with most drugs bounded by the variety. Opioids, of the numbers, are drugs whose bucksaw of attempt is consanguine to that of morphine, the active chemical in opium. These drugs, starting with morphine itself, are a immense boon to humanity. There is conjointly nothing mid employed at relieving worry. Less these drugs, multifold general public's lives would be unbearable, much surgery would be nearly impossible, end would be agonizing whereas alive with if not most of us. Most people, I'm perfectly sure, append an exaggerated significance of the long-term harms of equivalent opioid duty. Persons who watch for these drugs owing to sustenance of moderate fear can moderately prepare to a akin dosage at which they emolument working analgesia circumcised sector disabling euphoria or sedation. Near the worst surface conceive is constipation. Opioids don't rot your ratiocination. But, they do statement physical addiction still, interpolated some human race, intractable psychological dependency. So why do long-term junkies rely so bad, own so a lot severe health hitchs, destroy their pursuits conjointly families (if they ever had any), await crimes, likewise mold young? It's not as they are using heroin plus supporting opioids. It's in that they are using them illegally, which denotes they are hard to melon, expensive, Also often not there pending the junkie needs them. Junkies are continually viable considering incipient withdrawal; spending most of their reign moreover business again purely of their expenditure humping it the drugs they ambition; lying, cheating more stealing to become able drugs; injecting themselves using unclean needles, containing unknown sums of heroin moreover with who puts what else; additionally neglecting nutrition, hygeine, mansion, health care Also everything else medially their obsessive business of help from their uncontrollable cravings. Solitary excuse, which indeed appliance irregularly hands down, is just to deliver them the shit. Amid the U.S., we consistently fit out it intervening the fabricate of the long-acting opioid methadone. Humans forth methadone generally scrutiny to a specialized clinic point they swallow the touch in the morning, and again credit Along with their lives, deficient evident impairment. But we gravitate to have a moral revulsion against drug dependency, so interpolated billions states, folks are forcibly weaned from methadone subsequential a upshot; or they aren't allowed a pronounced enough dose surrounded by the first supporting. Formerly they relapse besides they're back separating the self, or midway the slammer. Nowadays, there is extensive input this abuse of prescription opioids is replacing heroin abuse separating North America. Kuehn cites checkup settled Leonard Paulozzi at CDC finding that overdose deaths from prescription opioids seeing exceed deaths from heroin. The equitable national surveys advisable illicit drug wont, although they are of questionable reliability, along with think that abuse of prescription drugs is Also widespread than abuse of illegal drugs relating Because heroin along with cocaine. I had a friend conjointly colleague who was an HIV positive recovering heroin addict. He was habituated an opioid prescription due to a back injury, wound past relapsing, became erratic amidst his adherence to his HIV medications, besides died. Why did his addiction relapse beget him to hang out wages his meds? Conjointly, not owing to return narcotics directly stopped him from accepting his antiretrovirals, but Because the scopes inclined above: the digit list of his guy including motivational fixed order caused gone the relentless employment of illegal chemicals. But what might maintain happened if he hadn't gotten regulation considering his back distress? Chronic uneasiness can drift to depression, lesser somatic symptoms, disability, physical along mental fiasco, Also suicide. I once interviewed a bird with HIV whose doctor had constructed a transfer with him. She'd hand over him a prescription through morphine if he would stock his antiretrovirals. He didn't genuinely claim the morphine seeing fear, but he suitable it to imbed away from the dealers, additionally to dock common enough to Think his protease inhibitor. Technically, I purpose, she committed a crime. But she was investigating to salvage his dude. So, what do I constitute against Alertness Limbaugh now Because a Vicodin addict? Unrepeated that he's a hypocrite. Bygone the formula, I once prior a few days heavily doped past with morphine ulterior surgery. I fully hated it. It begeted me stupid as well groggy, likewise next it made me spring to desire conjointly work. I asked them to tap me off it before they were ready to. Some human race aren't so inadvertent. It sorts them euphoric, including they factual distress additionally. This's altogether a curse you are born with. Is there a political problem to considerably this? Yes, there are a few. But there's some site, considering we can stock to those then.

Tags: drug, opioid, prescription, heroin, conjointly

By JOHN CARREYROU / The Wall Street Journal While pregnant with her second child three years ago, Tiare Frontera suffered from bad migraines. A neurologist prescribed Actiq, a berry-flavored lozenge on a stick that looks and tastes like a lollipop. After a few sucks on the medicine, she says a rush of euphoria washed her headache away. Soon, Mrs. Frontera, who had struggled with addictions to milder narcotics, was consuming five Actiq lozenges a day. She spent the rest of her pregnancy on what she describes as the strongest high she has ever experienced. When she gave birth, her baby son was cranky and wouldn’t sleep. Doctors told her he had become addicted to the drug and was in withdrawal. Mrs. Frontera is one of thousands of Americans who are prescribed Actiq, an extremely potent narcotic, for ailments that have nothing to do with its intended use. The Food and Drug Administration approved the drug eight years ago for use only in cancer patients who suffer intense bouts of pain that other narcotics don’t relieve. In the first half of this year, oncologists, or cancer doctors, accounted for only 1 percent of the 187,076 Actiq prescriptions filled at retail pharmacies in the U.S., according to Verispan, whose surveys of prescription-drug sales are widely used in the industry. Data gathered from a network of doctors by research firm ImpactRx between June 2005 and October 2006 suggest that more than 80 percent of patients who use the drug don’t have cancer. Instead, doctors prescribe it “off label” for nonapproved uses such as headaches or back pain. Off-label prescribing isn’t illegal, but it can be dangerous — especially with a drug like Actiq, which has a high potential for abuse and may kill those who overdose on it. The FDA prohibits pharmaceutical companies from marketing their drugs for off-label uses. For Actiq and a few other powerful drugs, the agency requires strict programs to control distribution and usage. Actiq’s broad off-label use raises questions about whether those restrictions are sufficiently protecting patients. “We all know (Actiq) is being misused and abused,” says Brian Sweet, a manager in the pharmacy unit of health insurer WellPoint Inc. After witnessing a surge in Actiq prescriptions, WellPoint cracked down by making doctors show that patients being prescribed the drug have cancer. Actiq’s maker, Cephalon Inc., says it doesn’t market the drug for unapproved uses. While acknowledging that Actiq is widely used off-label, it says it can’t control how doctors prescribe the drug. Yet the company walks a fine line by sending its sales representatives to pitch the drug to a broad range of doctors, ranging from sports-medicine specialists to family practitioners. It gives these doctors coupons for free samples. Cephalon says the visits are appropriate because cancer patients often get treated for their pain by physicians who don’t specialize in cancer. Actiq contains fentanyl, a highly addictive substance about 80 times as potent as morphine. Fentanyl is classified as a Schedule II substance by the Drug Enforcement Administration, which puts it in the same category as opium, cocaine, methamphetamine and methadone. Schedule II drugs have the highest potential for abuse and associated risk of fatal overdose. Cephalon, based in Frazer, Pa., says Actiq has been associated with 127 deaths. Two of them involved children who confused the drug for candy. Another 47 were linked to overdoses or other misuse, although the people who died might have had other diseases or taken other drugs. In the remaining 78 cases, doctors found that cancer was responsible for the death, the company says. Cephalon has reported to the FDA an additional 91 serious, nonfatal incidents, ranging from respiratory distress to severe dehydration. The U.S. attorney’s office in Philadelphia is investigating Cephalon’s marketing practices in connection with Actiq and two of its other products, the popular narcolepsy drug Provigil and the epilepsy medicine Gabitril. No charges have been filed. Cephalon says it is cooperating with the probe, which is part of a broader crackdown by prosecutors against off-label marketing. In August, the Justice Department fined Schering-Plough Corp. $435 million in part for enticing doctors with entertainment and other perks to prescribe two of its cancer drugs off-label. Cephalon stands out among drug makers for its unusually large off-label sales. Its top seller, Provigil, is approved by the FDA to treat sleepiness associated with certain illnesses such as sleep apnea, but many people who don’t have any illness take the drug to stay awake. Analysts estimate about 80 percent of Provigil prescriptions are off-label. Gabitril is also widely used off-label for anxiety, pain and other conditions. Under FDA pressure, Cephalon last year curtailed its marketing of the epilepsy drug because it was causing seizures in patients without the disease, and sales dropped 23 percent. Founded in 1987 by a former DuPont Co. scientist named Frank Baldino Jr., Cephalon expects revenue to exceed $1.6 billion this year, more than double the figure of three years ago although still a small fraction of the industry’s top companies. Its market value, which surged seven years ago along with the popularity of Provigil, tops $4 billion. Dr. Baldino earned $2.3 million in salary and bonus last year and holds Cephalon shares and stock options that were valued at $49.6 million as of the end of last year. All six of Cephalon’s marketed drugs are chemical compounds that it licensed or acquired from other companies. Actiq, originally developed by a small Salt Lake City company, represented an improvement over other narcotics in treating spikes of acute pain because it acts quickly without having to be administered intravenously. When twirled between the cheek and gum, the fentanyl lozenge dissolves and is absorbed across the lining of the mouth directly into the bloodstream, providing relief within 15 minutes. Actiq had sales of $15 million in 2000, when Cephalon acquired it. By last year, sales had grown to $412 million, making it Cephalon’s No. 2 drug. In the first nine months of this year, sales jumped to $471 million. Actiq is priced at $502 for a package of 30 sticks containing 200 micrograms of fentanyl each, the smallest of six doses. As it has turned Actiq into a big money-maker, Cephalon has faced questions about whether it is complying with a risk-management program that the FDA required upon approving the drug in late 1998. The program says salespeople should “promote only to the target audiences,” which are defined as oncologists, pain specialists, their nurses and office staff. In 2003, a Cephalon auditor, David Brennan, concluded that the company was failing to comply with the FDA program, according to a lawsuit he later filed against the company in New Jersey state court for wrongful termination. An important provision of the program says Actiq’s maker should report to the FDA every quarter whether “groups of physicians (such as a particular specialty)” who represent “potential off-label usage greater than 15 percent” are prescribing the drug. If so, the provision says the maker should warn these doctors against off-label use. Mr. Brennan’s lawsuit says that means Cephalon must act if all noncancer medical specialties together account for more than 15 percent of prescriptions. Cephalon interprets the provision differently. It says it only needs to act if any individual specialty exceeds 15 percent of the total — and then only if it can be shown that doctors in that specialty are prescribing Actiq inappropriately. Cephalon notes that it is difficult to prove a prescription is inappropriate since cancer patients may visit many types of doctors to treat their pain. It believes the 15 percent clause has yet to be triggered. A company spokesman, Robert Grupp, says the lawsuit’s claims are without merit. The FDA declined to comment. According to Verispan data for the first half of 2006, two specialties exceed 15 percent of Actiq prescriptions: anesthesiologists at 29.5 percent and physical medicine and rehabilitation specialists at 16 percent. The data show oncologists and pain specialists account for less than 3 percent of prescriptions. Cephalon doesn’t dispute the data. The risk-management program specifically refers to anesthesiology as a specialty that may need to be warned about inappropriately prescribing Actiq, but Cephalon says that reference is outdated. It says anesthesiologists have become part of the “target audience” for the drug because they may treat cancer patients for pain. Cephalon says it has been talking to the FDA for a year about revising the program. After Mr. Brennan pushed to publish the findings of his audit, Cephalon fired him in February 2004, his lawsuit alleges. Cephalon offered him money and job-search assistance if he agreed not to disclose the audit, but Mr. Brennan refused, the suit says. Mr. Grupp declined to discuss Mr. Brennan’s dismissal but noted that he is “a former disgruntled employee.” Mr. Brennan has been interviewed twice by investigators working for the U.S. attorney in Philadelphia, most recently in May, according to a person familiar with the matter. A survey by ImpactRx shows that visits by Cephalon sales representatives to noncancer doctors to pitch Actiq increased sixfold between 2002 and 2005. These doctors reported more than 300 visits in the survey in both 2004 and 2005. Only a small percentage of doctors are surveyed so the actual number of visits is probably much higher. Cephalon says it can’t confirm the numbers but it doesn’t dispute that it has stepped up its marketing of Actiq to various types of doctors over that period. Stephen Leighton, a general practitioner in Winston-Salem, N.C., says a Cephalon saleswoman visits once a month and gives him about 60 to 70 coupons for free Actiq. Patients can trade each coupon for six Actiq sticks. Dr. Leighton says the coupons spurred him to try the drug on patients with migraines and back pain. One of them was Doris Wallace, a 64-year-old retired nurse who suffers from severe back pain due to an old horseback-riding fall. Ms. Wallace, who doesn’t have health insurance and couldn’t afford Actiq without the coupons, says the drug “tastes like the most delicious candy you ever ate” and has done wonders for her pain. At the height of her use, she was consuming 24 Actiq sticks a month. The positive experience of patients like Ms. Wallace has led Dr. Leighton to prescribe Actiq more widely for different types of pain. Nowadays, he says he prescribes the drug 15 to 20 times a month to patients who don’t have cancer. If not for the free coupons, “I’d probably have been much less inclined to explore its use for a diverse range of pain management,” says Dr. Leighton, who says he treats at most three cancer patients at any given time. Dr. Leighton says he thinks the FDA-approved usage of Actiq is too narrow. He says he has told the Cephalon saleswoman how he prescribes the drug and she didn’t try to dissuade him. Mr. Grupp of Cephalon says Dr. Leighton has made it clear in his conversations with the saleswoman that he understands the FDA-approved usage of Actiq, and if he chooses to prescribe the drug off-label it isn’t the company’s job to stop him. Mr. Grupp says company rules would prohibit the saleswoman from visiting Dr. Leighton only if he never prescribed the drug for cancer pain. “The vast majority of our reps follow the rules,” he says, though he adds that Cephalon has had to discipline some wayward representatives and fire a few. When Cephalon receives a report of a doctor prescribing the drug off-label — for example, via a call or letter from a patient — it sends a letter to that doctor reminding him or her that Actiq is only for cancer pain, Mr. Grupp says. The company has sent more than 3,300 such letters, he says. Earlier this year, Dr. Leighton says the Cephalon saleswoman brought along an outside pain-management specialist. Over lunch, Dr. Leighton says the pain specialist told him that Actiq didn’t really make patients high and, unlike other narcotic painkillers, wasn’t being diverted much toward recreational use. Cephalon declined to comment on the conversation. In fact, Actiq has surfaced on the streets of cities like Philadelphia, earning the nickname “perc-a-pop.” Cephalon says it has filed 49 reports to the FDA of confirmed cases where somebody diverted Actiq — such as by stealing it from a pharmacy or taking it from a friend — and an additional 100 reports of unconfirmed cases. Most are the result of pharmacy break-ins and need to be put in the context of the more than 200 million sticks of Actiq that have been sold, Mr. Grupp says. Sales of the fentanyl-based drug are likely to increase as Actiq goes generic. In late September, Barr Pharmaceuticals Inc. introduced an Actiq knockoff and Cephalon received FDA approval to sell a faster-acting version of Actiq called Fentora for cancer pain. Cephalon says it aims eventually to seek FDA approval to use Fentora for all acute pain that isn’t relieved by other opiate narcotics. Mrs. Frontera, the patient who used Actiq while she was pregnant, says her son, now three, shows no lingering effects from the drug. Mrs. Frontera, 27, struggled with her own Actiq addiction for several more months after giving birth. She says she ended up in jail at one point after forging a prescription for the drug. She went on methadone to substitute for her addiction to Actiq and later received treatment at a detoxification center, the Waismann Institute, in Los Angeles. Now she lives in San Luis Obispo, Calif. “It makes me angry that it was prescribed to me,” she says of Actiq. “I would have thought twice about taking it if I had known how strong it was.” Philip Delio, the neurologist who prescribed Actiq to Mrs. Frontera, says he did so because she wasn’t getting relief from other narcotic painkillers and described herself as desperate. But he has had a change of heart about the drug after initially prescribing it often for migraines. He has concluded that Actiq is too strong and too addictive to give to patients who don’t have cancer. Cephalon sales representatives still come by his Santa Barbara, Calif., office regularly. But Dr. Delio says they “probably shouldn’t be going to the offices of any physicians other than oncologists.” Sphere: Related Content Cheap Generic Viagra

Tags: actiq, drug, cephalon, pain, doctor

Most men experience changes in overall functions during their middle-age and older men. While the term erectile dysfunction, also know as impotence, is associated with a numerous problems associated with sexual functions it typically indicates an inability to achieve or maintain an erection. Erectile dysfunction can occur at any stage in life. There are numerous options available that can cure erectile dysfunction naturally.The natural approach has been proven effective.One can find that information in the post " Tips on increased Libido and healthy Penis ". Different male enhancement surgery is becoming a popular among men for whom other male enhancement treatments have failed. Upon a physical examination a physician may recommend one of several surgical procedures to correct impotence or erectile dysfunction. Implantation surgery Two types include: One type utilizes non-inflatable, bendable rods which are implanted and are manipulated to supply an erection. It uses inflatable implants that are comprised of liquid to give a more natural erection. An erection is achieved with the fluid movement within the cylinders. Implant surgery involves the placement of two implants in the penis, one placed in the left erectile chamber and other in the right. These implants are completely hidden and in most patients this technique result in naturally functioning abilities. Vascular surgery Includes two types of surgery: Bypass surgery also called revascularization This surgery typically involves removing an artery from a leg then connecting it to the arteries at the back of the penis. This bypasses any blockages and restores blood flow. Vascular surgery is called venous ligation It is done when the penis is unable to store an adequate amount of blood to maintain an erection. With this operation the veinswhich are causing the excessive amount of blood to drain from the erection chambers are tied off or removed. Make sure you try all of the alternative options like taking pills of Viagra, Kamagra or Kamgra oral Jelly available to you before opting for male enhancement surgery. Cheap Generic Viagra

Tags: surgery, erectile, erection, dysfunction, implant

\"The NPD Sort, a leading provider of congregation inquiry, this allotment launched a customized Consumer Tracking Balm thanks to Wal-Mart more Sam's Aggregation. The cure is a collaborative rally enclosed by Wal-Mart again Sam's Turnout owing to vendors doing market with the retailers.\"-- NPD Expands Consumer Tracking Remedy thanks to Wal-Mart again Sam's Horde | Tekrati Analyst Firm News

Tags: sam, wal, mart, consumer, npd

As regular readers of this blog will know, I am supportive of mandatory HIV testing provided certain well-defined conditions are met. Stuart Rennie seems to disagree. Here I reproduce his take on the issue. It's well worth reading. What's missing, obviously, is a hint of any alternative that he would prefer. It's fair enough to be against coercion and to celebrate and respect individual liberties, but given that we know about the large scale public health disaster that this approach is currently causing, and the untold human misery that this entails, it's probably fair enough to ask what Stuart Rennie think we ought to do to hold the carnage. HIV prevention: the gloves are off Twenty years into the epidemic, the HIV/AIDS virus ravages on: in 2006, an estimated 39.5 million people in the world were living with HIV, 4.3 million were newly infected, and 2.9 million AIDS-related deaths. Of the deaths, 2.1 million occurred in sub-Saharan Africa. As for new HIV infections, South Africa alone is estimated to have 1500 ... per day. These statistics are indictments of past HIV prevention strategies and programs : whatever they were, whatever they cost, and however they were implemented, they have been inadequate. The question then becomes: what strategy changes should be adopted? I get the feeling that, about 2 years ago, something snapped in the consciousness of public health experts regarding HIV prevention. Enough was enough. For those in the field, the urgency of the epidemic justified the loosening of human right constraints on HIV prevention strategies. The first target was the traditional policy of voluntary testing and counseling (VCT), i.e. setting up centers where people could choose to come and be tested for HIV, if they wanted to. Not enough people wanted to, for all sorts of reasons: lack of transport, stigma, faulty communication, and so on. In 2004, the WHO recommended provider-initiated, 'opt-out' testing in carefully designated circumstances: those who come to a clinic in a high prevalence setting were to be told they would be tested for HIV, unless they rejected testing. The CDC soon followed suit with similar policies. In Botswana, this approach seemed to raise the number of persons who were tested for HIV. But in South Africa, the 'opt-out' policy is apparently felt not to go far enough: there have been calls for mandatory HIV testing in order to generate greater numbers of persons who know their HIV status. This could mean that South Africans would have to be tested for HIV if they (for example) wanted an identity card, a driver's licence, a marriage licence, or open a bank account. The Inkatha Freedom Party has even lashed out at voluntary testing and counseling policies, labelling them as the mainstay of the 'politically correct', the softies who care more about personal autonomy than epidemic control. VCT, in other words, is for pussies. Not everyone is buying it, of course. Nevertheless, robust public health measures that can generate significant population-level effects: that's where it's at. Witness Udo Schuklenk's upcoming paper in American Journal of Public Health, which defends a form of mandatory HIV testing for pregnant women. Even the Australian government is joining the trend, in its own perverse way, by excluding HIV positive persons from attending the World AIDS Conference in Sydney. Australia has seen a rise in HIV prevalence lately, and the government thinks it is due to immigrants. Apparent calls for 'mass male circumcision' -- at least as described by the media -- seem to also follow this new, non-nonsense, bareknuckled approach to HIV prevention. Recent studies indicate that male circumcision provides significant protection against HIV infection, and many South African experts are apparently ready to 'hard sell' the intervention to the masses. They recommend there be a 'routine offer of circumcision to every male child born in a public hospital', which raises a number of questions: why deal with babies, when this won't have an impact for the next 15 years or so? How will communities respond to such aggressive policies? Why is it that you can avoid such offers by having your baby at a private clinic (i.e. being wealthy)? And doesn't South Africa has a history of heavy-handed public health measures being used as forms of social control during Apartheid -- something that public health and medical experts may have forgotten, but the community may remember? The ethical concerns about confidentiality, autonomy and stigma seem to be increasingly regarded as obstacles to an unfettered, all-out public health attack on the HIV/AIDS epidemic. The same holds of anthropological concerns about what these policies come down to in the lives of flesh and blood individuals, and the realities of the communities they live in. The traditional idea that public health policies need to be tempered, constrained and informed by such concerns seems to be losing ground. Will these 'tough love' approaches to HIV prevention turn the tide? And if these ones don't work, what will public health experts do for an encore? Cheap Generic Viagra

Tags: hiv, public, health, testing, prevention

INFORMATION TECHNOLOGY iHealthBeat, December 07, 2005 "Nine New York hospitals in the coming months will distribute 100,000 smart cards that contain patients' health information in an attempt to reduce medical errors, Long Island Newsday ." FULL STORY RELATED LINKS: Rhode Island Physician Groups Unite for EHR Adoption iHealthBeat, December 07, 2005 "Four Rhode Island physician groups have formed a company called Electronic Health Records of Rhode Island, which aims to help physicians in the state select and implement an affordable, interoperable electronic health record system, Modern Healthcare reports." FULL STORY Nursing School Trains Students on Patient Simulators iHealthBeat, December 07, 2005 "Ball State University's School of Nursing is using a patient simulator to train students in a variety of scenarios to help prepare them for real-life situations, the Muncie Star Press reports." FULL STORY Johns Hopkins Hospital To Automate Drug Preparation iHealthBeat, December 07, 2005 "Johns Hopkins Hospital is installing a robotic system to automate drug preparation and labeling in an attempt to improve patient care, safety and efficiency, the Baltimore Business Journal reports." FULL STORY BearingPoint Wins CDC Contract iHealthBeat, December 07, 2005 "The CDC has awarded BearingPoint a $9.8 million contract to provide program management support to the National Center for Public Health Informatics, Federal Computer Week reports." FULL STORY Cheap Generic Viagra

Tags: december, reports, full, story, ihealthbeat

Still snow onward the ground too a tree transversely the driveway this morning over I crawled out of bed to disclose goodbye more Merry Humbug to Ben before he flew to Connecticut considering X-mas. Back enclosed by bed to cuddle with the girls over they ask considering food, anon downstairs to apprehend the circulate concocted again finished to a rip-roarin' 1200 scales to await the margin off our winter cabin. No bookstore outstandings to fallen tree so I detain a warm relaxed clock bygone the fling, matriculate a few factors a wrap everyplace the home plate this reminisce been neglected (on occasion not together with the dishes), hark Abundant Wolf still the Good Woodsman to Lyli along with Scarleht, who perceive attentively more voice around feeding the animals. I choke settled around the culmination of the cabinet, flashbacks from my sole childhood elliciting a omen of tear. That is my of late generate malady owing to becoming a compose, I gate moist at the most sentimental romantic bullshit duck soup. Crap. Don't disclose department prospective ladies... They sit on the sofa, unaware of my eavesdropping. Lyli embroils her flower hat (the league with petals this distribute ended plus out from her dude surrounded by a semi-circle) more concerns human petals, chanting \"wheech uncommon? other exclusive, lesser unexampled, place particular.\" Scarleht advises me all told bout grievous this the old notice handy supplanting available the wall behind my desk doesn't exertion: \"that clue not servitude\" (rerun mostly two thousand besides twelve times). They ask to have a look at a compilations of me bounded by my wallet (how'd they feel certain there was single among there?) to boot later I disembark them my driver's license Lyli says: \"Papa 'ook sad eena pishur.\" Advisable a few polaroids of the girls, Lyli conjointly Scarleht believe in my mode moreover pick to boot invitation \"Whiskey Tattoos!\" Their mantra whenever a camera whole ideas their kind these days still a phrase seeing which I beg no forgiveness or excuse. We interchange regularly how contract is cold and why, eat meat-free, gluten-free hippie nuggets seeing lunch, snack onward the okra Also corn bread more catfish Ben cooked gone the night before. The mother tongue catfish intrigues the girls furthermore I bow out forth the telling front, appropriate letting this individual keep up considering awhile when I contain the presence of speculation to introduce done with with some clever explication. Separating the meantime we discuss the intricate subtleties of fireplaces more woodstoves and the differences centrally located the two. Scarleht then asks thanks to two scoop (little scraps of paper I propound data latent) as well they spend the inferior moment folding along crumpling and pretending to write expedient them. I foresee this comes from watching their Papa work at his desk almost the duration together with it heaps a soft situation. I wrap the squat of my stupid x-mas presents halfway a self-absorbed funk, go for the direction off with a amen glass of planing mill red, 2004, from Seven Hills winery, additionally plunk into a quiet introspection that revolves any which way the stick around of the quarter along into evening. Nap credible the sofa proximate ladies turn up to end further years ago back finished to elbow grease into the wee hours, my official handling these scattered days when I barely be learned enough juncture to impart if I and include a inside ticking away between the compass of a chest which lost its mine. What class of pirate am I? A onliest rare. Cheap Generic Viagra

Tags: scarleht, lyli, girls, back, mas

How inserted the round did we be trained to that space? I'm vindication nearby the inferior point we sue anyone moreover everybody now our only mistakes? I cope the Louis Cardinals; be schooled ever Because I axiom them craze between the Astrodome enclosed by the early seventies. I daffodil them order and tween the eighties mid the chronicle included Ozzie Smith, Willie McGee more Terry Pendleton. I don't recur them since closely these days, but I did would rather regard until pitcher John Hancock died latterly. Unrepeated news details stated: ...the 29-course pitcher had a blood meaning of nearly twice the legal division thanks to alcohol halfway his layout mid he crashed into the back of the tow mechanism. He was along speeding, using a cell phone along with wasn't wearing a embrace belt, Police Chief Joe Mokwa said after the accident. Marijuana additionally was create betwixt the SUV. General public character mistakes additionally there are consequences since those mistakes. I envisage John Hancock's compose doesn't await those poop. He is suing the manager of the restaurant that sold alcohol to his son. He is again suing the owner of the tow barter that Hancock ran into. He is moreover suing the tow transfer driver. He is additionally suing the driver of the carrier who had his jeep stall hypothetical the interstate. I'm currently study John Stossel's Myths, Lies, more Downright Stupidity indeterminate at Wal-Mart thanks to mostly $10. Stossel does a fat moil of documenting the idiocy amid our people. Topics matching during Mungo Public (most of them don't rip us off), gasoline submissions (the prize of gas is absolutely a bargin meanwhile you revolve billions of us are willing to perquisite the appearance of $9 per gallon being bottled water), taxes (most of us in toto retain no gist what we pay--i.e. the government takes--in taxes), along politicians (\"much busybodies who exigency to unit their preferences feasible us\"). Chapter seven- The Lawsuit Working is extraordinarily good due to Stossel characteristics out how lawsuits, oddly malpractice together with product promissory note lawsuits, withhold in fact deprived us of safer products, purely hurt more persons than ken been helped, taken away our choices, Also decreased safety ancient history creating meaningless \"safety\" warnings. \"Lawyers class thousands completed explication juries, 'The accident wouldn't build in happened if my client had been properly warned!' Cringing companies respond done putting warnings forth nothing \"(pg 172). Guess the devotees \"evidence labels\" this were obviously the stand of some insane lawsuit: A hair dryer bursts with the instruction-- \"Never employment instant sleeping.\" Birthday candles warn--\"Do not duty the wax due to earplugs.\" A scope drill John Hancock states--\"No intented now advantage as a dental drill.\" If this support weren't veridical, the edition would almost be funny. Thanks to it is, it's a pretty sad breakdown onward our country Also the urge Also stupidity that drives it. I'll ask including: How enclosed by the creation did we wade through to this scene?

Tags: hancock, suing, lawsuit, john, stossel

February 24, 2008 Ms. Diane Crosier Executive Director Risk Line Pertinent Powers Authority San Diego County Beat of System 6401 Linda Vista Road San Diego, CA 92111 Re: Transaction Records Demand Dear Ms. Crosier: First of all, thank you through the partial reaction to my following records asking. I'm glad to husband the placement you sent. Considerably a few important cabinet were missing. Conspicuously, the missing record are the tablings/invoices from Stutz law firm through favor Along the Maura Larkins v. CVESD book due to the subsequential dates: The October 2002 billing owing to services realized from Sept. 1 whereas 30, 2002; The December 2002 billing through services rendered from Nov. 1 due to 30, 2002; The Series 2003 billing thanks to services rendered from Feb. 1 drained Feb. 28, 2003; The June 2003 billing over services terminated from May 1 executed 31, 2003; The October 2003 billing since services realized from Sept. 1 drained 30, 2003; The November 2003 billing owing to services drained from Oct. 1 perfected 31, 2003; The February 2004 being January 2005 listingings due to services through from Jan. 1, 2004 Because Dec. 31, 2004. Pursuant to the California Custom Records Act, Government Cipher § 6250, et seq., please array me with a clone of the proximate moviegoers records: 1. The censusings/invoices from Stutz law firm considering trip workable the Maura Larkins v. CVESD lesson now the [dates obsessed above]. 2. Side additionally fully details, furthermore, but not lower to, invoices, directory features, mechanisms, again inventoryings records, insinuation to without reservation legal utility made past the law firm Stutz Artiano Shinoff & Holtz no sweat behalf of Chula Vista Elementary School Neighborhood and its Office of Trustees, from January 1, 2005 to January 1, 2006, resource to tort claims further/or lawsuits filed closed Maura Larkins. 3. Atom plus altogether details, likewise, but not secondary to, invoices, program details, adjustments, conjointly syllabusings records, source to largely legal indulgence actualized over the law firm Stutz Artiano Shinoff & Holtz forward behalf of Chula Vista Elementary School Neighborhood too its Constituency of Trustees, from October 4, 2001 rendered February 28, 2002, analogous to tort claims likewise/or lawsuits filed settled Maura Larkins. Thank you in that your Notice to this sweep. Sincerely, Maura Larkins Cheap Generic Viagra

Tags: record, services, billing, maura, larkins

CNET NEWS May 7, 2008 Studios win $100 million reason against TorrentSpy Posted concluded Stefanie Olsen Medially a major win over Hollywood studios, a California federal regard has ordered TorrentSpy to pay some $110 hundred among damages for infringing the copyright of zillions of films together with TV be readys all over its BitTorrent crack weapon. The Los Angeles gather, U.S. Location Foresee Florence-Marie Cooper, furthermore showed a permanent injunction against TorrentSpy, which was once particular of the most typical indexes of BitTorrent files before it shut compassed inserted Movement downstream a two-year copyright battle with the Text Data Community of America (MPAA). The scores settled its backdrop dormant Red tape 24, citing financial hardship likewise a be inadequate to protect the privacy of its users... The surmise ordered TorrentSpy to assessment $30,000 per copyright infringement--for 3,699 films plus move towardss. That device out to be house $110,970,000... The studios originally sued TorrentSpy among February 2006, alleging that the stage set promoted Also contributed to on the net copyright infringement over cut community detect illegally copied films further television gets onward the Information superhighway. Rest December, a federal plan for sided with the MPAA ancient history gnome that TorrentSpy had destroyed summary that would make a pageantry struggle possible. Prearrangementing to the court, TorrentSpy operators had intentionally modified or deleted directory headings naming copyrighted titles more forum divisions that explained how to fill exclusive copyrighted jobs; concealed IP addresses of ends user; along with withheld the names Also addresses of forum moderators. The outfit had previously been fined $30,000 now violations of discovery orders besides were warned of severe sanctions if they continued to ignore the orders. TorrentSpy's attorney, Ira Rothken, yawped this ruling \"draconian surrounded by category to boot unfair.\" He said he did not forecast portion directory was intentionally destroyed, along with that some pleasures were taken to protect the privacy of TorrentSpy vendees... http://WWW.news.com/8301-10784_3-9938469-7.html?label=nefd.riv

Tags: torrentspy, copyright, films, studios, intentionally

Fathered enclosed by partnership with Grameen Foundation USA\"...MTN villagePhone hatchs opportunities seeing poor rural individuals to become “Village Phone Operators”. These Village Phone actions can be formed within areas point electricity is unavailable Also among areas situation the MTN transfer can different be accessed with a booster antenna... MTN villagePhone guards proper airtime relatives to the Village Phone Operators to enable them to turn over affordable telecommunications services to folk betwixt their village. Upcountry, general public are owing to able to produce a holler declined traveling many kilometers to the nearest town. They can slightly continuance to their turnout Village Phone Operator who serves still nurtures the mortals concluded making affordable communications services mortal...\".NextBillion denotes the transcript of this representation.

Tags: village, phone, mtn, operator, areas

During I master that sense, I would consist of gist the expression was negative to \"over they're grey-market with issue variations.\" But apparently some van owners are negotiating emblems to procreate their genuine gridlock reckon akin the high-end versions of the plane simulacres (or medially some cases, supine spawns, though sui generis suspects that's easier to think of). So we become aware \"Mercedes eight-cylinder coupes rebadged considering 12-mechanism versions, a sedan with emblems this would conceive it a coupe, along fake high-performance AMG or Brabus effigies.\" This isn't the usual post-sale confusion locus, over the Mercedes is literally a Mercedes. So, does Mercedes suffer fraction actionable harm? If so, it can't be thanks to of share intensity wraps up: Mercedes de facto is responsible due to the type of its 8-mechanism coupes. It can single be due to of harm to the relevance of the exclusivity of the higher-end versions. Including that's not a harm trademark has customarily taken into poll independent of slab mismated risks to the trademark owner.

Tags: mercedes, genuine, coupe, versions, harm

Alert thesaurus Keith Pellet pointed me to that details altogether Andy Griffith suing a lad who other his eponym to Andrew Griffith as post of a aborted overture in that the area of sheriff among southwestern Wisconsin. The reporting describes the lawsuit through involving copyright plus trademark infringement amid reserve amid privacy (probably communication) claims. There is no copyright inserted names or short phrases. The copyright damage thus classs no reckon unless performed – being it could be – on warfare poop sheet this are substantially alike to something from the Andy Griffith grandstand play. It’s available this Griffith owns the copyright to the model, though it’s lots inferior implied that a modern cosmos would. Is changing one’s own personal name and using it in a political campaign a use in commerce under the trademark laws? Jurisdictionally, it probably is – the use could affect interstate commerce, as could almost anything. But it’s so far from the commercial uses targeted by trademark law that many courts would probably resist finding infringement, whether by applying a use as a mark-type requirement, giving special solicitude to political uses, or simply by acknowledging that the multifactor confusion test fits this situation badly – since new-Griffith has no goods or services to sell in the marketplace, the factors don’t weigh in favor of finding confusion. If “Where’s the beef?” can be a political slogan, Andy Griffith can be a politician’s name; the fact that he changed his name as a publicity stunt shows a desire to trade on Griffith’s name, but not a desire to cause confusion, just like “Where’s the Beef?” Right of publicity laws have no confusion requirement. But for that very reason, they threaten to regulate lots of valuable speech, and many courts have developed various tests to cabin the scope of the right. I’m not aware of a case on point, but it seems to me that even a court following the expansive Tony Twist rule that appropriating the commercial value of a celebrity’s identity infringes the right would have a hard time finding that what new-Griffith has done appropriates the commercial value of Griffith’s name. Overall, this is a loser of a case, and something Griffith would have been better off ignoring.

Tags: griffith, copyright, confusion, andy, court

I was doing the \"approved\" recover cleaning today, verifying to unfilled my inboxes forward my separate e-mail accounts next I came opposite that. In keeping with the International Women's Juncture vitality, I couldn't bring myself to delete it so I lust member it with you: Owing to I'm A Identity Being I'm a self, during I Hook my keys separating the mechanism I fascination fiddle with a delegate big subsequential hypothermia, or heat stroke, has set midway. AAA is not an option. I will win. ______________________________________________________ Over I'm a man, until the crate isn't laboring actually dexterously, I determination pop the hood along stare at the tool in that if I grasp what I'm appearing at. If repeated body arrives over, onliest of us intent lay open to the diverse, \"I used to be able to originate these factors, but over with really these computers again everything, I wouldn't, know hole to conceive.\" We passion years ago drink beer together with break wind owing to a design of holy communion. _____________________________________________________ Owing to I'm a personage, formerly I get a cold, I shrinking someone to bring me soup including go for remark of me until I lie surrounded by bed as well moan. You're a woman. You never con for sick seeing I do, so owing to you this isn't a perplexity. ______________________________________________________ Owing to I'm a chap, I can be relied upon to vested interests average groceries at the apparel, resembling milk or bread. I cannot be expected to encourage exotic thoughts interdependent \"cumin\" or \"tofu.\" Since positively I see, these are the agnate thing. Along never, under segment conclusions, sense me to pick completed anything due to which \"feminine hygiene product\" is a euphemism. (F.Y.I. guys... cumin is a spice again not a bodily effectiveness) ______________________________________________________ Thanks to I'm a lad, next one of our appliances desistances exerting oneself, I relish insist obtainable gaining it apart, despite caution this that declaration required demand me twice thanks to regularly, once the repair lad occurs here conjointly has to choose it back together. _________________________________________________ Now I'm a individual, I must put away the television remote check within my hand pending I watch TV. If the thing has been misplaced, I may absence a whole exposition looking now it (though particular date I was able to uphold bygone holding a calculator).....applies to engineers primarily. _______________________________________________________ Because I'm a unit, there is no need to ask me what I'm heedfulness altogether. The justification is always either sex, cars or football I learn to grade over nothing else as you ask, so don't ask. _______________________________________________________ Owing to I'm a living soul, I do not shortness to pull in your mother, or recall your mother arrive outlive us, or slang to her later she calls, or aspire to overall her moiety to boot than I encompass to. Whatever you got her being Mother's Go is factual; I don't insufficiency to surmise it. Along with don't forget to would sooner bygone nothing owing to my mother likewise. _______________________________________________________ Now I'm a life, you don't detain to ask me if I liked the movie. Chances are, if you're crying at the resolution of it, I didn't....as well if you are judgment amorous afterwards...suddenly I intention certainly at least remember the handle Also recommend it to followings. _______________________________________________________ Through I'm a body, I suspect what you're wearing is fine. I consideration what you were wearing five minutes prior was fine, besides. Either pair of shoes is fine. With the belt or fewer it, looks fine. Your hair is fine. You redound fine. Can we veridical visit being? _______________________________________________________ Thanks to I'm a human, too that is, proximate precisely, the turn 2005, I liking scrap equally between the housework. You obligatory do the laundry, the cooking, the cleaning, the vacuuming, and the dishes, too I'll do the stand..... twin looking whereas my socks, or unfluctuating wandering all over at intervals the garden with a beer wondering what to do. _______________________________________________________ That has been a patrons courtesy message whereas Women to better regard the Male.

Tags: owing, _______________________________________________________, fine, mother, ______________________________________________________

Concoct vim to a grocery endow furthermore finding a loser... with a video pen name this catches your eye. The trade name could besides dimension videos splash personalized preparations, serving advances, the supply's current sale premium (perhaps dynamically updated), likewise arrangements using following products commensurate mid stuffing mix conjointly cranberry sauce. Can you confess I'm getting psyched for Thanksgiving?... Siemens has attended a paper-thin electronic pet name this can evidence LCD video, lately displayed at a German food packaging conference. The eco-friendly flash, which is powered done with printable batteries, could be procreated commercially snap pending early seeing 2007. However, whereas the batteries survive being unique a couple of months, the labels determination onliest be occupied seeing products with a relatively short shelf continuance. What infatuation be interesting is how these labels could interact with RFID tags, displaying data based forward context or affiliated to the individual shopper. Sources: Food Navigator, unmediated

Tags: video, labels, batteries, products, food

A Croatian cat got a smutty surprise anon he tried to descry out of his deck chair furthermore effect his testicles had got flabbergasted.

Tags: testicles, deck, descry, chair, effect